Louise Taylor Selected Research

Louise Taylor Research Topics

4	Prostatic Neoplasms (Prostate Cancer) 12/2019 - 09/2014
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 01/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 01/2018
2	Cystic Fibrosis (Mucoviscidosis) 05/2017 - 03/2014
2	Infections 05/2017 - 03/2014
1	Gaucher Disease (Gaucher's Disease) 01/2022
1	Cerebral Hemorrhage 01/2020
1	Neoplasms (Cancer) 12/2019
1	Myocardial Infarction 12/2018
1	Dementia (Dementias) 11/2017
1	Persistent Infection 03/2014
1	Pseudomonas Infections 03/2014
1	Rabies (Hydrophobia) 05/2013
1	Osteoarthritis 09/2012
1	Pain (Aches) 09/2012
1	Knee Osteoarthritis 09/2012
1	HIV Infections (HIV Infection) 03/2003

3	Prostate-Specific Antigen (Semenogelase)IBA 12/2019 - 01/2018
2	SolutionsIBA 05/2017 - 03/2014
2	Tobramycin (Nebcin)FDA LinkGeneric 05/2017 - 03/2014
1	Pharmaceutical PreparationsIBA 01/2022
1	taliglucerase alfaIBA 01/2022
1	Thrombin FDA Link 01/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2020
1	Kallikreins (Kallikrein)IBA 12/2019
1	Thrombopoietin ReceptorsIBA 01/2019
1	romiplostim FDA Link 01/2019
1	beta-Aminoethyl Isothiourea (AET)IBA 05/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2017
1	B-Cell Activating FactorIBA 01/2016
1	AutoantibodiesIBA 01/2016
1	B-Cell Maturation AntigenIBA 01/2016
1	Genetic Markers (Genetic Marker)IBA 09/2014
1	Antiviral Agents (Antivirals)IBA 05/2013
1	EndocannabinoidsIBA 09/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2012
1	CannabinoidsIBA 09/2012
1	AmidesIBA 09/2012
1	N- pyridazin- 3- yl- 4- (3- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)benzylidene)piperidine- 1- carboxamideIBA 09/2012
1	Naproxen (Naprosyn)FDA LinkGeneric 09/2012
1	Mitochondrial DNA (mtDNA)IBA 03/2003
1	Reverse Transcriptase InhibitorsIBA 03/2003
1	NucleosidesIBA 03/2003

5	Therapeutics 11/2017 - 03/2003
1	Self Administration (Administration, Self) 01/2019
1	Cardiac Rehabilitation 12/2018
1	Analgesia 09/2012